MedTrace Logo

Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome

NCT01372839 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2011-06-14

No results posted yet for this study

Summary

Compare with regular regimen, the aim of this study is to testify whether having more statin during PCI will benefit in Chinese population, and to find out optimal dose of the drug for patient after PCI.

Conditions

Interventions

DRUG

Atorvastatin

Atorvastatin 80mg/d ×2d before PCI. After PCI, atorvastatin 40mg/d until 30 days later, and then followed by usual care

DRUG

Statin

Usual care, but statin dose should not be higher than that described in exclusion criteria

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Yong Huo, MD · Division of Cardiology, Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372839 on ClinicalTrials.gov